Roland Willenbrock

3.8k total citations · 1 hit paper
55 papers, 2.9k citations indexed

About

Roland Willenbrock is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Roland Willenbrock has authored 55 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Roland Willenbrock's work include Heart Failure Treatment and Management (28 papers), Hormonal Regulation and Hypertension (9 papers) and Cardiovascular Function and Risk Factors (8 papers). Roland Willenbrock is often cited by papers focused on Heart Failure Treatment and Management (28 papers), Hormonal Regulation and Hypertension (9 papers) and Cardiovascular Function and Risk Factors (8 papers). Roland Willenbrock collaborates with scholars based in Germany, United States and Canada. Roland Willenbrock's co-authors include Rainer Dietz, P Aubry, Sven‐Göran Fransson, Ruth H. Strasser, P. Aspelin, K. J. Berg, Thomas Langenickel, Dankward Hänlein, Sebastian Philipp and Bertram Pitt and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Roland Willenbrock

54 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nephrotoxic Effects in High-Risk Patients Undergoing Angiography

2003 775 citations P. Aspelin, P Aubry et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roland Willenbrock Germany	20	1.4k	651	600	597	556	55	2.9k
Haim Hammerman Israel	32	2.3k 1.6×	358 0.5×	387 0.6×	965 1.6×	542 1.0×	85	4.2k
Dennis V. Cokkinos Greece	25	764 0.5×	229 0.4×	295 0.5×	416 0.7×	377 0.7×	93	1.8k
Jan Menne Germany	23	1.6k 1.1×	701 1.1×	674 1.1×	498 0.8×	251 0.5×	59	3.0k
Shin Takiuchi Japan	31	2.5k 1.7×	201 0.3×	503 0.8×	512 0.9×	397 0.7×	87	3.9k
Rolf Ekroth Sweden	24	739 0.5×	226 0.3×	188 0.3×	133 0.2×	386 0.7×	86	1.9k
Yuichiro Maekawa Japan	35	2.2k 1.5×	228 0.4×	123 0.2×	700 1.2×	699 1.3×	201	3.8k
Tsuneo Takenaka Japan	32	1.1k 0.7×	990 1.5×	359 0.6×	614 1.0×	306 0.6×	126	2.7k
Georgios Chalikias Greece	27	812 0.6×	262 0.4×	135 0.2×	264 0.4×	341 0.6×	85	1.8k
Mias Pretorius United States	27	707 0.5×	330 0.5×	252 0.4×	177 0.3×	156 0.3×	59	1.7k
Pasquale Mastroroberto Italy	24	1.3k 0.9×	175 0.3×	173 0.3×	183 0.3×	500 0.9×	118	2.4k

Countries citing papers authored by Roland Willenbrock

Since Specialization

Citations

This map shows the geographic impact of Roland Willenbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Willenbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Willenbrock more than expected).

Fields of papers citing papers by Roland Willenbrock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Willenbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Willenbrock. The network helps show where Roland Willenbrock may publish in the future.

Co-authorship network of co-authors of Roland Willenbrock

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Willenbrock. A scholar is included among the top collaborators of Roland Willenbrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Willenbrock. Roland Willenbrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Philipp, Sebastian, Jan Steffen Jürgensen, Jens Fielitz, et al.. (2006). Stabilization of Hypoxia Inducible Factor Rather than Modulation of Collagen Metabolism Improves Cardiac Function After Acute Myocardial Infarction in Rats. European Journal of Heart Failure. 8(4). 347–354. 55 indexed citations

Fielitz, Jens, Sebastian Philipp, Lars R. Herda, et al.. (2006). Inhibition of Prolyl 4-Hydroxylase Prevents Left Ventricular Remodelling in Rats with Thoracic Aortic Banding. European Journal of Heart Failure. 9(4). 336–342. 14 indexed citations

Philipp, Sebastian, et al.. (2005). The impact of anaemia and kidney function in congestive heart failure and preserved systolic function. Nephrology Dialysis Transplantation. 20(5). 915–919. 19 indexed citations

Philipp, Sebastian, Ines Pagel, Jens Lutz, et al.. (2004). Regulation of Caspase 3 and Fas in Pressure Overload-Induced Left Ventricular Dysfunction. European Journal of Heart Failure. 6(7). 845–851. 18 indexed citations

Aspelin, P., P Aubry, Sven‐Göran Fransson, et al.. (2003). Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. New England Journal of Medicine. 348(6). 491–499. 775 indexed citations breakdown →

Dickstein, Kenneth, et al.. (2003). Inhibition of both neutral endopeptidase and endothelin converting enzyme lowers pulmonary pressures in congestive heart failure. Journal of the American College of Cardiology. 41(6). 266–266. 2 indexed citations

Mitrović, Veselin, Roland Willenbrock, Marija Miric, et al.. (2003). Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. American Heart Journal. 145(3). E14–E14. 22 indexed citations

Aspelin, P., et al.. (2002). Nephrotoxicity in high-risk patients. A double-blind, randomized multicenter study of iso-osmolar and low-osmolar nonionic contrast media : The nephrotoxicity, high risk, iso-osmolar, contrast media (NEPHRIC) study.. The American Journal of Cardiology. 90. 2 indexed citations

Scheuermann‐Freestone, Michaela, et al.. (2001). A New Model of Congestive Heart Failure in the Mouse Due to Chronic Volume Overload. European Journal of Heart Failure. 3(5). 535–543. 33 indexed citations

10.

Willenbrock, Roland, et al.. (1999). Acute hemodynamic and renal effects of adrenomedullin in rats with aortocaval shunt. European Journal of Pharmacology. 369(2). 195–203. 5 indexed citations

11.

Willenbrock, Roland. (1999). Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt. Cardiovascular Research. 42(3). 733–742. 11 indexed citations

12.

Willenbrock, Roland, et al.. (1999). Renal Function in High-Output Heart Failure in Rats. Journal of the American Society of Nephrology. 10(3). 572–580. 6 indexed citations

13.

Willenbrock, Roland, et al.. (1998). Influence of angiotensin on ANP release and renal response to volume expansion in moderate heart failure. Journal of the American College of Cardiology. 31. 428–428. 1 indexed citations

14.

Dietz, Rainer, Rüdiger von Harsdorf, Johannes Krämer, et al.. (1998). Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death. Basic Research in Cardiology. 93(0). s101–s108. 14 indexed citations

15.

Dietz, Rainer, et al.. (1998). Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion. European Journal of Pharmacology. 347(2-3). 245–252. 2 indexed citations

16.

Osterziel, K.J., Oliver Strohm, Jochen Schuler, et al.. (1998). Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. The Lancet. 351(9111). 1233–1237. 279 indexed citations

17.

Willenbrock, Roland, et al.. (1996). Acute and Chronic Neutral Endopeptidase Inhibition in Rats With Aortocaval Shunt. Hypertension. 27(6). 1259–1266. 21 indexed citations

18.

Tremblay, Johanne, Céline Huot, Roland Willenbrock, et al.. (1993). Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.. Journal of Clinical Investigation. 92(5). 2499–2508. 44 indexed citations

19.

Fischer, Thomas, Markus Haass, Rainer Dietz, et al.. (1991). Transcription, storage and release of atrial natriuretic factor in the failing human heart. Clinical Science. 80(4). 285–291. 12 indexed citations

20.

Willenbrock, Roland, Johanne Tremblay, R. García, & Pavel Hamet. (1989). Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.. Journal of Clinical Investigation. 83(2). 482–489. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact